{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:32:58Z","timestamp":1787167978378,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.lungcan.2022.01.008","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T10:54:30Z","timestamp":1642848870000},"page":"98-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers"],"prefix":"10.1016","volume":"167","author":[{"given":"Anne","family":"Mc Leer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Foll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Brevet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Antoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Novello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Mondet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Cadranel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Giaj Levra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Demontrond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Audigier-Valette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Letouz\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Lantu\u00e9joul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynnette","family":"Fernandez-Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Moro-Sibilot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.lungcan.2022.01.008_b0005","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1158\/1078-0432.CCR-12-2246","article-title":"Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers","volume":"19","author":"Yu","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.lungcan.2022.01.008_b0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"75","key":"10.1016\/j.lungcan.2022.01.008_b0015","article-title":"Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors","volume":"3","author":"Sequist","year":"2011","journal-title":"Sci Transl Med 3:75ra26"},{"issue":"2","key":"10.1016\/j.lungcan.2022.01.008_b0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11523-014-0332-y","article-title":"Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLC","volume":"10","author":"Bosc","year":"2015","journal-title":"Target Oncol"},{"issue":"9","key":"10.1016\/j.lungcan.2022.01.008_b0025","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jamaoncol.2016.1304","article-title":"Prospective Study of Repeated Biopsy Feasibility and Acquired Resistance at Disease Progression in Patients With Advanced EGFR Mutant Lung Cancer Treated With Erlotinib in a Phase 2 Trial","volume":"2","author":"Redig","year":"2016","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.lungcan.2022.01.008_b0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jtho.2018.08.2028","article-title":"A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics","volume":"14","author":"Ferrer","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2022.01.008_b0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1200\/JCO.18.01585","article-title":"EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes","volume":"37","author":"Marcoux","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.lungcan.2022.01.008_b0040","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.jtho.2019.06.002","article-title":"Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes","volume":"14","author":"Offin","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"26","key":"10.1016\/j.lungcan.2022.01.008_b0045","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1200\/JCO.2016.71.9096","article-title":"Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas","volume":"35","author":"Lee","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2022.01.008_b0050","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/S1470-2045(14)71180-5","article-title":"Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin","volume":"16","author":"Oser","year":"2015","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2022.01.008_b0055","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7377","article-title":"RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer","volume":"6","author":"Niederst","year":"2015","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.lungcan.2022.01.008_b0060","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.lungcan.2022.01.008_b0065","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/bioinformatics\/btv098","article-title":"Sambamba: fast processing of NGS alignment formats","volume":"31","author":"Tarasov","year":"2015","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.lungcan.2022.01.008_b0070","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lungcan.2022.01.008_b0075","article-title":"From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline","author":"Auwera","year":"2013","journal-title":"Curr Protoc Bioinformatics"},{"issue":"3","key":"10.1016\/j.lungcan.2022.01.008_b0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.lungcan.2022.01.008_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl Variant Effect Predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.lungcan.2022.01.008_b0090","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-018-0531-8","article-title":"Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations","volume":"10","author":"Tamborero","year":"2018","journal-title":"Genome Med.."},{"issue":"6","key":"10.1016\/j.lungcan.2022.01.008_b0095","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/bioinformatics\/btl646","article-title":"A faster circular binary segmentation algorithm for the analysis of array CGH data","volume":"23","author":"Venkatraman","year":"2007","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.lungcan.2022.01.008_b0100","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/gb-2009-10-11-r128","article-title":"Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays","volume":"10","author":"Popova","year":"2009","journal-title":"Genome Biol."},{"key":"10.1016\/j.lungcan.2022.01.008_b0105","doi-asserted-by":"crossref","unstructured":"J. Shinde, Q. Bayard, S. Imbeaud, et al., Palimpsest: an R package for studying mutational and structural variant signatures along clonal evolution in cancer, 2018 Doi: 10.1093\/bioinformatics\/bty388.","DOI":"10.1093\/bioinformatics\/bty388"},{"issue":"1","key":"10.1016\/j.lungcan.2022.01.008_b0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01358-x","article-title":"Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis","volume":"8","author":"Letouz\u00e9","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.lungcan.2022.01.008_b0115","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1101\/gr.125567.111","article-title":"Mutual exclusivity analysis identifies oncogenic network modules","volume":"22","author":"Ciriello","year":"2012","journal-title":"Genome Res."},{"issue":"1","key":"10.1016\/j.lungcan.2022.01.008_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-020-0873-9","article-title":"Pan-cancer molecular analysis of the RB tumor suppressor pathway","volume":"3","author":"Knudsen","year":"2020","journal-title":"Commun Biol"},{"issue":"7","key":"10.1016\/j.lungcan.2022.01.008_b0125","doi-asserted-by":"crossref","first-page":"e41017","DOI":"10.1371\/journal.pone.0041017","article-title":"Loss of activating EGFR mutant gene contributes to acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer cells","volume":"7","author":"Tabara","year":"2012","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.lungcan.2022.01.008_b0130","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41416-019-0573-8","article-title":"Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer","volume":"121","author":"Leonetti","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2022.01.008_b0135","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/gcc.20137","article-title":"High-resolution chromosome arm 5p array CGH analysis of small cell lung carcinoma cell lines","volume":"42","author":"Coe","year":"2005","journal-title":"Genes Chromosom. Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2022.01.008_b0140","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/path.4853","article-title":"Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D","volume":"241","author":"Simbolo","year":"2017","journal-title":"J. Pathol."},{"issue":"8","key":"10.1016\/j.lungcan.2022.01.008_b0145","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ejca.2015.03.010","article-title":"Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation","volume":"51","author":"Huang","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.lungcan.2022.01.008_b0150","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1158\/1078-0432.CCR-17-2655","article-title":"Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis","volume":"24","author":"Chang","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2022.01.008_b0155","doi-asserted-by":"crossref","unstructured":"N. Srinivas, S. Rachakonda, R. Kumar, Telomeres and Telomere Length: A General Overview. Cancers (Basel) 12:558, 2020.","DOI":"10.3390\/cancers12030558"},{"issue":"5","key":"10.1016\/j.lungcan.2022.01.008_b0160","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/med.21674","article-title":"Targeting telomerase for its advent in cancer therapeutics","volume":"40","author":"Bajaj","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.lungcan.2022.01.008_b0165","unstructured":"Centre Hospitalier Universitaire de Besancon: Anticancer Therapeutic Vaccination Using Telomerase-derives Universal Cancer Peptides in Metastatic Non Small Cell Lung Cancer\u00a0: A Phase I\/II Study [Internet]. clinicaltrials.gov, 2021[cited 2021 Dec 14] Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02818426."},{"issue":"4","key":"10.1016\/j.lungcan.2022.01.008_b0170","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.molcel.2020.10.033","article-title":"Impact of Lineage Plasticity to and from a Neuroendocrine Phenotype on Progression and Response in Prostate and Lung Cancers","volume":"80","author":"Rubin","year":"2020","journal-title":"Mol. Cell"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222000095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222000095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:59:48Z","timestamp":1759237188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500222000095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":34,"alternative-id":["S0169500222000095"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.01.008","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}